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doi:10.1016/j.jtcvs.2007.06.010bjective: Small bronchioloalveolar carcinoma showing pure ground-glass opacity
n high-resolution computed tomographic scans is commonly multifocal. Surgical
reatment for these lesions is controversial. We discuss the efficacy of video-assisted
horacic surgery for multifocal bronchioloalveolar carcinoma in patients at our
nstitution.
ethods: Twenty-seven patients with multifocal bronchioloalveolar carcinoma le-
ions less than or equal to 20 mm in diameter (105 lesions) underwent video-assisted
horacic surgery pulmonary resection between 2000 and 2006. Their clinicopatho-
ogic features were investigated retrospectively.
esults: Twenty-seven patients (10 male and 17 female) with a median age of 64
ears (range, 41–78 years) had 91 ground-glass opacity lesions on high-resolution
omputed tomography. Sixteen patients (59%) were women with no history of
moking. The distribution of bronchioloalveolar carcinoma lesions was unilateral in
4 patients and bilateral in 13 patients. Ten patients underwent wedge resection.
eventeen patients underwent single-stage segmentectomy or lobectomy (alone or
ith wedge resection) for technical reasons. All lesions were completely resected.
ne patient underwent conversion to thoracotomy for bleeding. Histologic diag-
oses showed 62 bronchioloalveolar carcinoma type A lesions, 28 type B lesions,
nd 15 type C lesions according to Noguchi’s classification, and atypical adenoma-
ous hyperplasia in 43 lesions (13 patients). All patients had N0 disease. The median
ostoperative observation period was 46 months. All patients have survived to date,
ut new lesions have developed in 7 (26%). Patients with new lesions had a higher
ncidence of bronchioloalveolar carcinoma lesions of 3 mm or less in diameter (P
0254) and atypical adenomatous hyperplasia (P  .011).
onclusion: Video-assisted thoracic surgery management of multifocal bronchi-
loalveolar carcinoma yielded satisfactory results. However, the appearance of new
esions remains a problem.
ronchioloalveolar carcinoma (BAC) is a subtype of adenocarcinoma and has
a broad spectrum of radiographic and pathologic appearances.1-3 As the
result of recent advances in diagnostic imaging modalities, the detection rate
f multifocal BAC showing pure ground-glass opacities (GGOs) on high-resolution
omputed tomographic (HRCT) scanning has increased. In the recently revised
istologic classification of lung and pleural tumors,4 nonmucinous BAC was clearl
efined as a form of adenocarcinoma with a pure bronchioloalveolar growth pattern
nd no evidence of stromal, vascular, or pleural invasion. The present article
iscusses the efficacy of limited surgical resection of focal BAC.5-11 The optimal
anagement of multifocal early-stage BAC has not been clearly determined. In
any cases the focal BAC of 20 mm or less in diameter showing pure GGO is notnvasive. Therapeutic guidelines, such as the optimal duration of observation and
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TSptimal treatment strategy, have not yet been establis
e have been surgically treating selected patients w
ultifocal BAC with video-assisted thoracic surge
VATS) in our department. In this retrospective study,
ocused on resected multifocal early-stage BAC and stud
he correlation between pathologic features and rad
raphic appearances, the prognosis, and the problems.
aterials and Methods
his study was approved by the Toranomon Hospital Instituti
eview Board of Clinical Research. Informed consent from
ients was waived because of the retrospective study design.
From January 2000 to December 2006, 939 patients under
urgery for primary lung cancer in our department. Retrospe
xamination of their records indicated that in 27 patients, p
rative computed tomography (CT) had revealed the presenc
ultifocal GGO lesions. Patients with multiple lesions that 
ll classified as BAC type A or B because of their pure
ppearance on HRCT were observed for at least 6 months
ATS resection was planned if the size or density of the l
ncreased or did not change. Single-stage surgical treatment 
ndertaken in 26 patients with performance status 0-1 an
redicted postoperative forced expiratory volume in 1 secon
ore than 800 mL who consented to single-stage surgery. 
tage surgical treatment was undertaken in 1 patient at her re
he site of the cancer, preoperative respiratory complications,
stimated postoperative respiratory function were taken into c
ideration when determining the best surgical procedure for 
ndividual patient. Wedge resection with VATS was selected a
rimary therapy for cases with BAC type A or B accordi
oguchi’s classification.12 In cases with multiple GGO lesio
onfined to a single lobe or a GGO lesion located deep 
ilum, VATS segmentectomy or VATS lobectomy was perform
or technical reasons. In cases involving wedge resection,
esected specimens underwent intraoperative frozen-section exa
nation. If frozen-section results indicated a positive staple 
argin, reexcision was performed. If frozen-section results i
ated BAC type C with active fibroblastic proliferation, conver
o VATS lobectomy was undertaken.
Lesions visualized mainly as GGOs that were less than 20
n diameter and deep in the lungs (20 mm from the pulmona
urface) were marked under CT guidance the day before
peration, using VATS markers with a hook wire, because 
perative palpation under thoracoscopic observation would 
Abbreviations and Acronyms
AAH  atypical adenomatous hyperplasia
BAC  bronchioloalveolar carcinoma
CT  computed tomography
GGO  ground-glass opacity
HRCT high-resolution computed tomography
VATS  video-assisted thoracic surgeryifficult. w
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s
.
o
he
ATS Procedures
ll procedures were performed using 3 access ports (7
nd 11.5 mm in diameter) without minithoracotomy. VA
edge resection was performed using an endo-stapler
esection and suturing techniques. In lobectomy and 
entectomy, the endo-stapler was used to staple the 
ronchus and vessels after dissection. One of the 3 wo
as extended by 20 to 40 mm to remove the specime
etal chest retractor was not used in this incision; instead a
5-mm diameter silicon rubber instrument (Lap Protector
inimini, Hakko, Tokyo, Japan) was applied to maintain
he wound and provide access for an extra instrument for
ediastinal lymph node sampling.
Follow-up information was obtained from 6-month fol-
ow-up visits and CT scans. The cumulative survivals were
alculated using the Kaplan–Meier method.
esults
f the 939 patients with primary non–small cell lung cancer
ABLE 1. Characteristics of 27 patients with multifocal
ronchioloalveolar carcinoma
haracteristics Years n
ge range (mean) 41–78
(64.3)
27
Male 10
Female 17
ymptoms
Yes 0
No 27
etection of GGO
CT mass-screening 18
Incidental 9
moking history
No. (female) 18 (16)
Current or ex-
smoker
9
istory of malignant
disease
No 19
Yes 8 (1)*
o. of GGOs on HRCT
(total 91)
(colon 3, thyroid 3,
uterus 1, kidney
1, prostate 1)
2
10
9
1
1
7 4
AC, Bronchioloalveolar carcinoma; GGO, ground-glass opacity; HRCT,
igh-resolution computed tomography; CT, computed tomography. *History
f malignancy at 2 sites (thyroid and uterus)ho underwent pathologically complete resection during
ber 2007
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TShe study period, 104 patients (11%) were diagnosed 
AC 20 mm or less in diameter on examination o
rozen section, and 27 (26%) of those 104 had multi
AC. The characteristics of patients with multifocal B
re listed in Table 1. There were 10 men and 17 wome
 median age of 64 years (range, 41–78 years). Si
atients (59%) were women with no history of smoking
atients were asymptomatic with multifocal GGOs detec
n helical CT during screening for lung cancer or inv
ation of other conditions. The number of lung tumors
atient ranged from 1 to 8 (mean 3.4), including 
isualized as almost pure GGOs on HRCT.
urgical Procedures
he surgical procedures are shown in Table 2. All p
ures were performed using VATS. Preoperative percu
eous CT-guided marking using a hook wire was perfor
or 36 GGOs in 22 patients (78%). There were no s
omplications from the marking procedures. Single-sta
urgical resection was performed in 26 patients, and 2-s
ilateral wedge resection was performed in 1 patient a
equest. Wedge resections were performed in 10 pati
unilateral 6, bilateral 4) in whom intraoperative fro
ection showed that the surgical margins were free of 
ype A or B. Three patients underwent segmentectom
ith wedge resection) for a deep pulmonary lesion (2
ients) or BAC type C on intraoperative frozen sectio
atient). Fourteen patients underwent lobectomy (simp
obectomy, 3 patients; with wedge resection, 10 patie
ilobectomy, 1 patient) for multiple lesions in a lob
atients) or BAC type C (7 patients). One patient under
onversion from segmentectomy using VATS to thoracot-
ABLE 2. Surgical procedures (video-assisted thoracic su
urgical procedure Unila
14
edge resections (2-stage) 6 (0)
egmentectomy (plus wedge resection) 3 (2)
obectomy 5
Simple lobectomy 3
Plus ipsilateral wedge resection 2
Plus contralateral wedge resection
Bilobectomy
ymph node dissection
Hilar node/mediastinal sampling
onverted to thoracotomy
eason for segmentectomy or lobectomy
BAC type C
Multifocal lesions in a lobe
Deep in parenchyma
T-guided markers 22 (10 pa
ATS, Video-assisted thoracic surgery; BAC, bronchioloalveolar carcinommy for bleeding. In 11 of 14 patients who underwent c
The Journal of Thoracice
l
ith
l
-
r
-
s
r
-
t
obectomy, mediastinal lymph node sampling was per-
ormed without lymph node dissection (ND1/sampling 
/11).
athologic Examination
inety-one GGO lesions less than or equal to 20 mm in
iameter were detected on preoperative HRCT. Postop-
rative histopathologic examination diagnosed 105 BAC
esions and 43 atypical adenomatous hyperplasia (AAH)
esions. The final histopathologic diagnoses of the 105
AC lesions in 27 patients are presented in Table 3
nal diagnosis was BAC type A in 62 lesions, type B in
8 lesions, and type C in 15 lesions. Thirteen patients
ith multifocal BAC lesions had 2 primary cancers, 7
atients had 3 primary cancers, 1 patient had 4 primary
ancers, 2 patients had 7 primary cancers, 1 patient had 8
rimary cancers, 2 patients had 10 primary cancers, and
patient had 12 primary lung cancers. No lymph node
etastases were detected in any patients who underwent
) and operative findings in 27 cases
Bilateral Total
13 n  27
4 (1) 10
0 3
9 14
8
1
6/11
1*
17
9
6
2
s) 14 (12 patients) 36 (22 patients)
, computed tomography. *VATS segmentectomy converted thoracotomy.
ABLE 3. Relationships between size and pathology (105
ronchioloalveolar carcinoma lesions and 43 atypical ad-
nomatous hyperplasia lesions)
Size
athology <10 mm 10–20 mm Total
BAC type A 58 4 62
BAC type B 17 11 28
BAC type C 2 13 15
AH 43 0 43
AC, Bronchioloalveolar carcinoma; LBAC, localized bronchioloalveolarrgery
teral
tientarcinoma; AAH, atypical adenomatous hyperplasia.
and Cardiovascular Surgery ● Volume 134, Number 4 879
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G
TSegmentectomy or lobectomy. The most advanced les
n any of the 27 patients was classified as stage
hirteen of 27 patients (48%) had 43 AAHs (ra
–12). Six of seven patients (86%) with more than 4 
esions had AAH.
elationships Between Computed Tomographic
indings and Pathologic Diagnoses
he relationship between preoperative radiologic findin
nd final pathologic diagnoses is shown in Table 4. Thi
atients had a different number of BAC lesions on p
ogic examination from the number of GGO lesions see
RCT. Eleven of these 13 patients (85%) had AAH. Al
ll pure GGOs measuring less than 10 mm in diameter
iagnosed as BAC type A or B. Two lesions less th
m in diameter were diagnosed as BAC type C, but 
pectively the HRCT of these patients showed mixed G
esions with an 85% GGO component. The number of 
esions was less than the number of GGO lesions on H
n 4 patients with AAH and was more than the number of
GO lesions on HRCT in 9 patients.
ostoperative Course
elayed pulmonary fistulas persisting for 5 or more days
ere found in 4 patients. There were no other serious
omplications, and all patients were able to walk without
ssistance on the day after the operation. The mean length of
ostoperative hospitalization was 7.3 days (range, 4–18
ABLE 4. Mismatches between pathologic diagnosis and
esions
o. Operation BAC (right/left)
BAC size (mm)
(right/left)
Unilateral A1, B1 5, 8
Unilateral A1, B1 10, 17
Unilateral A3 3, 5, 6
Unilateral A4 4, 5, 6, 7
Unilateral A1, B1 8, 8
Unilateral A2 1, 4
Unilateral A1, B1 4, 6
Bilateral A1/C1 6/10
Bilateral A2/B1 4, 5/8
0 Bilateral A2, B3/A1, C2 4, 5, 6, 7/4, 4, 12, 20
1 Bilateral A5, B3/A1, B1 1, 3, 4, 4, 5, 3, 4, 20/6,
2 Bilateral B1/A3, B2, C1 10/3, 4, 5, 8, 10, 18
3 Bilateral A1/A11 12/1-16
4 Bilateral A3, B1, C1/A2, B2, C1 1, 1, 18, 6, 9/7, 4, 5, 9,
5 Bilateral A4, B1/A1, B1 3, 3, 6, 11, 3/3, 6
AC, Bronchioloalveolar carcinoma; AAH, atypical adenomatous hyperplas
esions  20 mm on high-resolution computed tomographic scanning. †Thays). o
80 The Journal of Thoracic and Cardiovascular Surgery ● Octo.
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utcomes
he median postoperative follow-up period was 46 months
range, 3–81 months). At the time of writing, all patients are
till alive. However, de novo lesions developed in 7 of 27
atients (26%) (disease-free interval, 6–30 months). The
-year disease-free survivals of patients with multifocal BAC
as 70.3%, with no difference in outcome between the surgi-
al treatments (reduction surgery, wedge resection, or segmen-
ectomy 75%, lobectomy 65.3%; P  .611). The new lesions
hat developed after resection were visualized as small pure
GOs (range, 1 to multiple) and were not invasive in any of
he cases. Patients with new lesions had a higher incidence of
AC lesions of 3 mm or less in diameter (P  .0254) and
AH (P .011). Chemotherapy was not administered to these
atients, at their request. The patients are still being followed
p by CT scan every 6 months. Further therapeutic planning
ill occur if there is any suggestion of invasion on HRCT,
uch as increased internal density.
iscussion
ecent advances in diagnostic radiographic techniques and
he introduction of helical CT have increased the detection
ate of early-stage lung cancer. The correlation between
GO on CT and pathologic findings has been studied.13 The
eplacing growth of adenocarcinoma cells along the alveolar
all is reflected as a GGO appearance with patent alveolar
paces and small airways on HRCT. A solid lesion on CT
epresents the collapse of the alveoli, subsequent formation
iologic lesions and relationship with postoperative new
Radiologic
lesions
< 20 mm*
Pathologic
BACs
< 20 mm† *† AAH (n)
Postoperative
new lesions DFI (mo)
3 2 2 1 None
3 2 2 1 2 12
2 3 1 4 1 20
3 4 1 2 None
1 2 1 0 None
1 2 1 0 None
2 2 0 1 7
3 2 2 1 None
7 3 2 5 Multiple 30
6 8 1 1 None
9 10 1 10 3 9
5 7 1 2 None
2 12 1 12 None
8 10 1 1 1 23
7 7 0 1 6
I, disease-free interval. *The number of preoperative ground-glass opacity
ber of BAC lesions  20 mm diagnosed histologically.rad
6
6
ia, DFf a fibrotic focus, and proliferation of tumor cells.14 Even
ber 2007
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G
TSmall tumors have the potential for mediastinal lymph node
etastasis, and lobectomy with systematic lymph node dis-
ection is considered standard therapy for many cases of
on–small cell lung cancer. Noguchi and colleagues12 clas-
ified surgically resected peripheral type adenocarcinomas
f 20 mm or less in diameter into 6 groups (types A to F)
ccording to their clinicopathologic characteristics. Type A
localized BAC) and type B (localized BAC with foci of
lveolar structural collapse) showed a 100% 5-year survival
fter lobectomy with systematic nodal dissection and no
ymph node metastases. The present article discusses the
fficacy of limited surgical resection (wedge resection or
egmentectomy) of early-stage BAC presenting as small
ure GGO on HRCT.5-11
Barsky and colleagues15 published their genetic researc
f BAC using a novel strategy for clonality determination.
hey determined that these tumors were mostly multifocal
ndependent cancers, and that lung-sparing operations
wedge resections) should therefore be performed. In some
eports, 18% to 20% of BAC were multifocal. However, the
ost suitable timing and method of surgical resection for
ultifocal BAC is still controversial. There are as yet no
herapeutic guidelines. At our institution, we made deci-
ions about the timing and method of surgical treatment
ccording to the HRCT images and the results of intraop-
rative frozen-section pathologic examination. Staged re-
ection may cause considerable physical stress and also
isks cancer progression. We therefore recommend single-
tage, aggressive, curative pulmonary resection using
ATS in all cases with helical CT images indicating mul-
ifocal BAC. Performance status, pulmonary reserve, and
atient consent for single-stage surgery should be taken into
onsideration. VATS gives a wide view of intrathoracic
tructures and is minimally invasive. However, one of the
isadvantages is that tumors, especially those visualized as
ure GGOs, cannot be directly manipulated, necessitating
reoperative CT-guided marking. If no pneumothorax oc-
urred, marking was performed multiple times in the same
atient if needed, including for bilateral lesions.16 Each site
as marked according to the location of the lesion. When
edge resection was planned, the marker was set on the
pposite side of lesions near the interlobular region and at
he base of lesions in other regions, so that all lesions would
e included if the resection was performed up to the level of
he markers. For segmental resection of a small deep lesion
sing VATS, the staple line placement depended on tumor
ocation. The CT-guided marking was a reliable surgical
uide for placement of the staple line for parenchymal
ivision. The staple line could be placed beyond the ana-
omic border of the diseased segment, enabling VATS tu-
or resection with a safe surgical margin.
In 13 patients, there was a difference between the num-er of preoperative GGO lesions on HRCT and the number i
The Journal of Thoracicf BAC lesions diagnosed histologically. This may be the
esult of limitations of CT resolution and the presence of
AH. It has been suggested that AAH is the adenoma in an
denoma-carcinoma sequence in the lung periphery. Chap-
an and Kerr17 reported that AAH was found in 23.4%
ungs with adenocarcinoma, and that a greater percentage of
omen (30%) than men (18.8%) with adenocarcinoma had
AH. In our series of 27 patients who underwent operations
or multifocal pure GGO lesions, 13 (48%) had an AAH
esion on histopathologic examination. AAH was classified
s a preinvasive lesion of adenocarcinoma by the World
ealth Organization in 1998,18 because many investigator
ad provided evidence of a sequence from AAH to adeno-
arcinoma, especially BAC.19 It seems to be difficult 
iscriminate AAH from noninvasive BAC preoperatively,
ecause of the similar appearances of the focal, round GGO
esions without a solid component on HRCT. The most
dvanced lung cancer lesion in all our 27 patients was class
A. All of the patients are still alive, but de novo lesions
eveloped in 7 of 27 patients (26%). There are no previous
ata regarding the development of new BAC lesions after
urgical resection of multifocal BAC. In our study, patients
ith new lesions after resection had a higher incidence of
AC lesions of 3 mm or less in diameter (P  .0254) and
AH (P  .011). Three patients with new lesions had a
hort disease-free interval (10 months), which might be
ecause the new lesions already existed at the time of
peration even though they were not seen on preoperative
T. Five of the seven patients with new lesions were
iagnosed with multifocal BAC with AAH. Our results
upport a sequence from AAH to BAC.
The new lesions developing after resection were seen as
ure GGOs less than 10 mm in diameter. These lesions were
ot invasive in any of the cases, and the patients are still
eing followed up by CT scan every 6 months. The time
aken for BAC to become invasive is still unknown. Further
xamination of the therapeutic strategy is necessary by
ccumulating a larger number of cases and comparing the
ecurrence rates and outcomes in the course observation
roup, chemotherapy only group, surgery only group, and
urgery plus postoperative chemotherapy group. However,
n our report, aggressive VATS pulmonary resection for the
atients with pure GGOs more than 10 mm in diameter who
ere observed for at least 6 months may be accepted be-
ause half of these pure GGOs more than 10 mm in diam-
ter were BAC type C.
Recently, the relationship between mutation of the epi-
ermal growth factor receptor gene and the therapeutic
fficacy of the selective inhibitor of epidermal growth factor
eceptor gene tyrosine kinase (ZD1839 or Iressa) in patients
ith multifocal BAC has been reported.20 We propose tonvestigate this further in our department.
and Cardiovascular Surgery ● Volume 134, Number 4 881
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G
TSIn our study, VATS management for multifocal BAC
esions was less invasive than other procedures and was
easible even for single-stage bilateral surgical resection. If
e decide to perform further resection for new lesions that
ppear after the initial resection, the first operation should
e performed with VATS because it is less invasive, par-
icularly in relation to the effect on postoperative respiratory
unction, and causes fewer adhesions between the lung and
he chest wall.
onclusions
ATS pulmonary resection of multifocal BAC may be
ssociated with a favorable outcome, even with bilateral
esions, in selected patients in whom complete resection is
easible. However, the size of the subject population and
uration of follow-up were insufficient to properly deter-
ine the effectiveness of VATS management for these
atients. Postoperative patients need careful follow-up be-
ause new lesions may develop. Therapeutic guidelines
hould be established for these new lesions.
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